CLPBY Coloplast A/S

OTC
$7.35

Coloplast A/S (CLPBY) is expected to report earnings on February 2, 2027, before the market open. The consensus earnings estimate is $0.10 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +2.3% since its last earnings release on November 3, 2026.

Coloplast A/S Reported Earnings
Tuesday, November 3, 2026 · 12:00 AM ET
Earnings Date
1st Quarter, Dec 2026
Feb 2
Tuesday · Before Open
Earnings Whisper
-
vs $0.10
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $7.43

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Coloplast A/S

Coloplast A/S engages in the development and sale of intimate healthcare products and services principally in Denmark, the United States, the United Kingdom, France and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology and Advanced Wound Care segments. Coloplast A/S is based in Humleb?k, Denmark.

Sector

Healthcare

Industry

Medical Instruments/Supply

Charts powered in part by Lightweight Charts™ by TradingView.